At the news
? NEUTRALIMPACT 2/10 144 filed Nov 9, 2026 at 17:28 ET
Jonathan P. DiVincenzo, an officer of Bio-Rad Laboratories, filed a Form 144 notice of intent to sell 919 shares of common stock, with an approximate market value of $359,000 based on the filing. The shares were acquired as restricted stock on October 24, 2025, and the proposed sale is scheduled for November 9, 2026. The sale represents a small fraction of the company's $9.9B market cap and is likely a routine diversification trade by an officer.
- Jonathan P. DiVincenzo, an officer of Bio-Rad, filed Form 144 to sell 919 shares of common stock.
- The approximate market value of the proposed sale is $358,842 (based on 919 shares at the filing reference price of ~$390.47 per share).
- Shares were acquired as restricted stock on October 24, 2025, via an issuer transaction.
- The proposed sale date is November 9, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access